Search Results - "Khalif, Igor"

  • Showing 1 - 17 results of 17
Refine Results
  1. 1

    FERGIcor, a Randomized Controlled Trial on Ferric Carboxymaltose for Iron Deficiency Anemia in Inflammatory Bowel Disease by Evstatiev, Rayko, Marteau, Philippe, Iqbal, Tariq, Khalif, Igor L, Stein, Jürgen, Bokemeyer, Bernd, Chopey, Ivan V, Gutzwiller, Florian S, Riopel, Lise, Gasche, Christoph

    Published in Gastroenterology (New York, N.Y. 1943) (01-09-2011)
    “…Background & Aims Iron deficiency anemia (IDA) is common in chronic diseases and intravenous iron is an effective and recommended treatment. However, dose…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Inflammatory bowel disease treatment in Eastern Europe: current status, challenges and needs by Khalif, Igor L, Shapina, Marina V

    Published in Current opinion in gastroenterology (01-07-2017)
    “…To analyze the available studies of course, diagnosis and treatment of Inflammatory bowel disease (IBD) in Eastern Europe. According to published data, full…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Irritable bowel syndrome in the Russian Federation: results of the ROMERUS multicenter observational study by Maev, I V, Okhlobystina, O Z, Khalif, I L, Andreev, D N

    Published in Terapevtic̆eskii arhiv (24-02-2023)
    “…Irritable bowel syndrome (IBS) is one of the most common functional disorders of the gastrointestinal tract. According to Russian guidelines, a standard…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Interactions between symptoms and motor and visceral sensory responses of irritable bowel syndrome patients to spasmolytics (antispasmodics) by Khalif, Igor L, Quigley, Eamonn M M, Makarchuk, P A, Golovenko, O V, Podmarenkova, L F, Dzhanayev, Y A

    “…to evaluate and correlate the symptomatic, motor and sensory responses to two widely used categories of spasmolytic agents in irritable bowel syndrome (IBS)…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13

    Ferric Carboxymaltose Prevents Recurrence of Anemia in Patients With Inflammatory Bowel Disease by Evstatiev, Rayko, Alexeeva, Olga, Bokemeyer, Bernd, Chopey, Ivan, Felder, Marcel, Gudehus, Maja, Iqbal, Tariq, Khalif, Igor, Marteau, Philippe, Stein, Jürgen, Gasche, Christoph

    Published in Clinical gastroenterology and hepatology (01-03-2013)
    “…Background & Aims Iron-deficiency anemia is the most common systemic complication of inflammatory bowel diseases (IBD). Iron-deficiency anemia recurs…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Multiple Cytokine Profiling: A New Model to Predict Response to Tumor Necrosis Factor Antagonists in Ulcerative Colitis Patients by Obraztsov, Igor Vladimirovich, Shirokikh, Katerina Evgenievna, Obraztsova, Olga Isaakovna, Shapina, Marina Vladimirovna, Wang, Ming-Hsi, Khalif, Igor Lvovich

    Published in Inflammatory bowel diseases (21-02-2019)
    “…Abstract Background and Aims Ulcerative colitis (UC) is a form of inflammatory bowel disease, and antibodies against tumor necrosis factor (anti-TNF) are used…”
    Get full text
    Journal Article
  16. 16

    Vedolizumab for inflammatory bowel diseasesI by Igor L. Khalif, M. V. Shapina

    “…Aim of review. To present literature data on administration of vedolizumab at inflammatory bowel diseases. Summary. The vedolizumab is anti-α4β7-integrin…”
    Get full text
    Journal Article
  17. 17

    Colonic growth factors (G-CSF, GM-CSF) and chemokines (MCP-1, MIP-1β) in severe ulcerative colitis by Konovich, Ye.A., Shirokikh, K.Ye, Shapina, M.V., Khalif, I.L.

    “…Aim of investigation. To determine the content of growth factors (G-CSF, GM-CSF) and chemokines (MCP-1, MIP-1β) in resected colon specimens of patients with…”
    Get full text
    Journal Article